Developing a home test for early lung cancer detection using cheek cell analysis
Translating buccal nanocytology for lung cancer screening into clinical practice
This study is working on an easy at-home test that lets people check for early signs of lung cancer using cells from their cheeks, making it simpler for more folks to get screened and catch any issues early.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10997166 on NIH RePORTER |
What this research studies
This research aims to create a simple, at-home test that allows individuals to screen for early-stage lung cancer by analyzing cells collected from the inside of their cheeks. The test focuses on examining chromatin architecture, which can reveal changes associated with lung cancer risk. By identifying patients who may need further evaluation, such as a CT scan, this approach seeks to improve early detection rates, especially among those who might not typically qualify for standard screening methods. The goal is to make lung cancer screening more accessible and effective for a broader population.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of smoking or those exposed to second-hand smoke, as well as non-smokers at risk for lung cancer.
Not a fit: Patients who are already diagnosed with advanced lung cancer or those without any risk factors for lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of lung cancer, significantly improving treatment outcomes and survival rates.
How similar studies have performed: Previous research has shown promise in using non-invasive methods for cancer detection, indicating that this approach could be a viable option for lung cancer screening.
Where this research is happening
Chicago, UNITED STATES
- Northwestern University — Chicago, United States (Active)
Researchers
- Principal investigator: Backman, Vadim — Northwestern University
- Study coordinator: Backman, Vadim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.